Doctor Yu He

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Follow

Contributor content

Developing p21-activated kinase 1 (PAK1) activators to treat hypertrophic cardiomyopathy (HCM)

Presentation

Developing p21-activated kinase 1 (PAK1) activators to treat hypertrophic cardiomyopathy (HCM)

ESC 365 is supported by

novartis

Explore sponsored resources